logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 865 2352511, +7 865 2353229.

E-mail
medvestnik@stgmu.ru

Evalution of the neurospecific autoantibodies level in patients with Covid-19: preliminary report

[Abstracts]
Vladimir Baturin; Vladimirovna Kostrovskaya Marina; Ekaterina Vladimirovna Grudina; Mariya Baturina; Arevik Arkadyevna Fil; Vasiliy Fisher; Volkov Evgeny; Tanzilya Adamovna Dotdaeva;

In severe COVID-19 patients the blood level of autoantibodies (IgG) to neurospecific proteins was determined. It defined the marked increase in autoantibodies to peripheral myelin protein, protein lipid protein, S100 protein, type 2 dopamine receptors and dopamine. At the same time, it was designate the relationship between the levels of autoantibodies to the S100 protein and NMDA receptors. High levels of specific IgG to SARS-CoV-2 S-trimer Protein coincided with high levels of autoantibodies to S100 protein and NMDA receptors.

Download

References:
1. Muravyeva A. A., Obedin A. N., Zinchenko O. V., Vladimirova O. V., Mazharov V. N. [et al.]. Experience in treatment of patients with the new Coronavirus Infection – COVID-19 complicated with pneumonia in the intensive care department of a city hospital. Medicinskii vestnik Severnogo Kavkaza. – Medical News of North Caucasus. 2020;15(3):404-407. (In Russ.). https://doi.org/10.14300/mnnc.2020.15096
2. Bartsch Y. C., Wang C., Zohar T. Atyeo C., Burke J. S. [et al.]. Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nature Medicine. 2021. https://doi.org/10.1038/s41591-021-01263-3
3. Wang E. Y., Mao T., Klein J., Dai Y., Huck J. D. [et al.]. Diverse functional autoantibodies in patients with COVID-19. medRxiv. 2020:2020.12.10.20247205. https://doi.org/10.1101/2020.12.10.20247205
4. Zuo Y., Estes S. K., Ali R. A., Gandhi A. A., Yalavarthi S. [et al.]. Prothrombotic antiphospholipid antibodies in COVID-19. medRxiv 2020;2020.06.15.20131607. https://doi.org/10.1101/2020.06.15.20131607
5. Kurushina O. V. Barulin A. E. Porazheniya central’noj nervnoj sistemy pri COVID-19. Zhurnal nevrologii psihiatrii im. S. S. Korsakova. – Korsakov Journal of Neurology and Psychiatry. 2021;121(1):92-97. (In Russ.). https://doi.org/10.17116/jnevro202112101192

Keywords: COVID-19, autoantibodies, S100 protein, NMDA receptors, dopamine receptors, dopamine, peripheral myelin protein, myelin proteolipid protein


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy